remediation – Pharma GMP

Top Line Clearance Checklist Gaps Found in FDA 483s

digi — Wed, 26 Nov 2025 01:39:04 +0000

Top Line Clearance Checklist Gaps Found in FDA 483s Effective Line Clearance Checklist for Production: Addressing Common Gaps Cited in FDA 483 Observations The line clearance process represents a critical step within pharmaceutical manufacturing, ensuring cleanliness, correct materials, and proper documentation before initiating each production batch. Regulatory inspectors from agencies like the FDA frequently cite...

Common Warehouse GMP Deficiencies and How to Address Them

digi — Tue, 25 Nov 2025 04:51:04 +0000

Common Warehouse GMP Deficiencies and How to Address Them Addressing Common Deficiencies in GMP Warehouse Management for Pharmaceuticals Good Manufacturing Practice (GMP) warehouse management for pharmaceuticals is a critical component of the pharmaceutical supply chain and quality system. Warehouses serve as vital nodes where raw materials, in-process products, and finished goods are stored under controlled...

GMP CFR 21 Part 11: Gap Assessment and Remediation Planning

digi — Sat, 15 Nov 2025 08:50:47 +0000

GMP CFR 21 Part 11: Gap Assessment and Remediation Planning Comprehensive Guide to GMP CFR 21 Part 11 Gap Assessment and Remediation Planning Pharmaceutical manufacturing and related regulated industries are governed by stringent data integrity requirements. The GMP CFR 21 Part 11 regulation, issued by the US Food and Drug Administration (FDA), delineates criteria under...

FDA Data Integrity Case Studies: Lessons From Real Inspections

digi — Sat, 15 Nov 2025 08:32:47 +0000

FDA Data Integrity Case Studies: Lessons From Real Inspections Comprehensive Step-by-Step Guide on FDA Data Integrity Case Studies and Compliance Data integrity remains a paramount concern within pharmaceutical manufacturing and regulatory oversight globally. Agencies such as the FDA, EMA, and MHRA emphasize strict adherence to drug cgmp requirements, with particular attention to the principles of...

FDA Data Integrity Warning Letters: Common Pitfalls and How to Avoid Them

digi — Sat, 15 Nov 2025 08:02:47 +0000

FDA Data Integrity Warning Letters: Common Pitfalls and How to Avoid Them Understanding FDA Data Integrity Warning Letters: A Comprehensive Step-by-Step Prevention Guide Ensuring trustworthy data is a fundamental requirement in pharmaceutical manufacturing and quality assurance. With increasing regulatory scrutiny, the United States Food and Drug Administration’s (FDA) focus on data integrity has resulted in...